Latest news with #ADIA
News18
5 days ago
- Business
- News18
ADIA seeks CCI nod to acquire minority stake in Micro Life Sciences
New Delhi, Jul 24 (PTI) Abu Dhabi's sovereign wealth fund ADIA has sought approval from the Competition Commission of India (CCI) to acquire a 3 per cent stake in medical devices firm Micro Life Sciences Pvt Ltd (Meril) in a USD 200 million deal. The development came after a wholly-owned subsidiary of Abu Dhabi Investment Authority (ADIA) on Monday said it has entered into definitive agreements to invest USD 200 million for a 3 per cent stake in Meril. ADIA, through its affiliate Platinum Jasmine A 2018 Trust (acting through its trustee Platinum Owl C 2018 RSC Ltd), is acquiring a stake in Gujarat-based Meril. 'The acquirer (Platinum Jasmine A 2018 Trust) proposes to subscribe to certain equity shares proposed to be issued by the target (Micro Life Sciences) and acquire certain equity shares of the target from Bilakhia Holdings Pvt Ltd, amounting to approximately 3.06 per cent shareholding in the target," according to a notice filed with the CCI on Wednesday. Platinum Jasmine A 2018, Trust and Micro Life Sciences said the proposed transaction does not have any impact on any relevant market in India, let alone any appreciable adverse effect on competition, and therefore, the definition of the relevant product and geographic market may ultimately be left open. Following the transaction, ADIA said this investment values the firm (MERIL) at an enterprise value of USD 6.6 billion. Founded by the Bilakhia Group, Meril is a global innovator in medical technology with a focus on clinically advanced solutions across multiple specialities, including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics and surgical robotics. Headquartered in Vapi, Gujarat, Meril employs more than 13,000 people, has over 35 global subsidiaries, and serves healthcare systems in around 150 countries. 'This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our…clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions," Sanjeev Bhatt, Senior Vice President – Strategy at Meril, said. Established in 1976, ADIA is a globally diversified investment institution that prudently invests funds on behalf of the Abu Dhabi government through a strategy focused on long-term value creation. PTI HG HG BAL BAL view comments First Published: July 24, 2025, 21:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Zawya
22-07-2025
- Business
- Zawya
ADIA to invest $200mln in India's $6.6bln medical device firm Meril
The Abu Dhabi Investment Authority (ADIA) plans to invest $200 million in the Indian medical devices company, Micro Life Sciences Private Limited (Meril). A wholly-owned subsidiary of ADIA has entered into an agreement for an approximate 3% stake in Meril. The investment values the Gujarat-based Meril at $6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Founded by the Bilakhia Group, Meril operates across multiple specialties including cardiovascular, structural heart, orthopaedics, and surgical robotics. ADIA, which established a subsidiary at the Gujarat International Finance Tec-City (GIFT City) last October with plans to set up a $4-$5 billion fund in the special economic zone, has been increasing its India investments over the past year, including in healthcare and pharmaceuticals. Earlier, ADIA acquired a 3% stake in Intas Pharmaceuticals, for approximately $250–$270 million, which valued the Indian firm at around $8.5 billion. The Abu Dhabi sovereign wealth fund also emerged as a key investor in India's Akums Drugs and Pharmaceuticals July IPO, allocating 500 million rupees ($6 million), and representing 6.03% of the anchor investment portion. (Writing by Bindu Rai, editing by Seban Scaria)
Time of India
22-07-2025
- Business
- Time of India
ADIA invests $200 million in medical devices co Meril
Representative image NEW DELHI: Abu Dhabi Investment Authority (ADIA), UAE's largest sovereign wealth fund, has entered into a definitive agreement to invest $200 million (around Rs 1,700 crore) for a 3% stake in Meril (Micro Life Sciences), a medical devices company. This investment values Meril at an enterprise value of $6.6 billion (around Rs 56,000 crore), says a company statement. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this deal, Meril will be backed by two globally recognised investors — ADIA and Warburg Pincus, it adds. In 2022, Warburg Pincus announced that it will invest $210 million for a minority stake in Meril. Sanjeev Bhatt, senior vice president — strategy, Meril, said: 'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions. This investment will enable us to accelerate growth, attract worldclass talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Founded by the Bilakhia Group, Meril has a strong focus on clinically-advanced solutions across multiple specialties — including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical robotics. Headquartered in Vapi (Gujarat), Meril operates state-of-theart, vertically integrated, and globally certified manufacturing and R&D facilities. Established in 1976, ADIA is a globally diversified investment institution that invests funds on behalf of the Abu Dhabi govt through a strategy focused on long-term value creation. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Economic Times
21-07-2025
- Business
- Economic Times
ADIA signs a definitive agreement to invest $200 million in medical devices firm Meril
Abu Dhabi Investment Authority (ADIA) has signed a definitive agreement to invest $200 million (about Rs1,725 crore) for a 3% stake in medical devices maker Micro Life Sciences Pvt Ltd (Meril). The investment by a wholly-owned subsidiary of ADIA pegged Meril's enterprise valuation at $6.6 billion, the Vapi, Gujarat-based company said in a statement. Post the investment, Meril will be backed by two major global investors ADIA, and US private equity firm Warburg Pincus. The deal is subject to Competition Commission of India (CCI) approval. 'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions,' said Sanjeev Bhatt, senior vice president-strategy at Meril. 'This investment will enable us to accelerate growth, attract world-class talent, and further strengthen clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Meril was founded in 2006 by the Bilakhia Group after divesting their agrochemical business to Bayer, and the Micro lnks business to Hubergroup—both from Germany. In 2022, the promoters tapped Warburg Pincus to raise Rs 1,575 crore by selling a 14% stake in Meril, and Rohit Kothari's Anchorage Capital for Rs 200 crore by divesting a 2% stake at a valuation of about Rs 11,000 crore. In the three years since, Meril closed fundraisings for another 3% shareholdings while its valuation surged more than fivefold to nearly Rs 60,000 crore. The Bilakhia family currently has more than 81% stake in the company, with Warburg, ADIA, and Kothari being other principal shareholders together holding nearly 19%.Meril is regarded as an innovator in medical technology (MedTech), with a focus on clinically-advanced solutions across multiple specialties such as cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics and surgical robotics. Some of the innovations include transcatheter heart valve series, transcatheter edge-to-edge repair system, and surgical robotic system. The company is growing between 30-35% compounded annually, with FY25 revenue at Rs 4,800 crore and margins of 27-28%. Exports contributed about 55% of expect the company to double revenue within less than three years. Meril employs more than 13,000 employees and has over 35 global subsidiaries. Its Vapi facility spans over 100 acres with over 1 million sq ft manufacturing space.
Time of India
21-07-2025
- Business
- Time of India
ADIA signs a definitive agreement to invest $200 million in medical devices firm Meril
Abu Dhabi Investment Authority (ADIA) is set to invest $200 million for a 3% stake in medical device maker Meril, valuing the company at $6.6 billion. This investment, pending CCI approval, will support Meril's growth and research efforts. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Abu Dhabi Investment Authority (ADIA) has signed a definitive agreement to invest $200 million (about Rs1,725 crore) for a 3% stake in medical devices maker Micro Life Sciences Pvt Ltd ( Meril ).The investment by a wholly-owned subsidiary of ADIA pegged Meril's enterprise valuation at $6.6 billion, the Vapi, Gujarat-based company said in a the investment, Meril will be backed by two major global investors ADIA, and US private equity firm Warburg Pincus . The deal is subject to Competition Commission of India (CCI) approval.'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions,' said Sanjeev Bhatt, senior vice president-strategy at Meril. 'This investment will enable us to accelerate growth, attract world-class talent, and further strengthen clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions .'Meril was founded in 2006 by the Bilakhia Group after divesting their agrochemical business to Bayer, and the Micro lnks business to Hubergroup—both from 2022, the promoters tapped Warburg Pincus to raise Rs 1,575 crore by selling a 14% stake in Meril, and Rohit Kothari's Anchorage Capital for Rs 200 crore by divesting a 2% stake at a valuation of about Rs 11,000 crore. In the three years since, Meril closed fundraisings for another 3% shareholdings while its valuation surged more than fivefold to nearly Rs 60,000 Bilakhia family currently has more than 81% stake in the company, with Warburg, ADIA, and Kothari being other principal shareholders together holding nearly 19%.Meril is regarded as an innovator in medical technology (MedTech), with a focus on clinically-advanced solutions across multiple specialties such as cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics and surgical robotics. Some of the innovations include transcatheter heart valve series, transcatheter edge-to-edge repair system, and surgical robotic company is growing between 30-35% compounded annually, with FY25 revenue at Rs 4,800 crore and margins of 27-28%. Exports contributed about 55% of expect the company to double revenue within less than three employs more than 13,000 employees and has over 35 global subsidiaries. Its Vapi facility spans over 100 acres with over 1 million sq ft manufacturing space.
